Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-25

Clinical Trial Update: Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating psilocybin-assisted psychotherapy for post-traumatic stress disorder in military veterans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • psilocybin-assisted psychotherapy (psilocybin)

Snippet

Sponsor: Combat Stress | Conditions: PTSD | Phase 2 | Status: UNKNOWN